In June 2009, I first told you about the FDA's plan to develop “Risk Evaluation and Mitigation Strategies” (or REMS) in an attempt to reduce prescription drug abuse by limiting access to opioid medications. The ideas they were considering would have made it a great deal more difficult for chronic pain patients to get the medications they need.
At that time, the FDA provided an online form where you could express your opinion on the issue. Although the initial comment period ended on...

